By Owen Tucker-Smith
Bruker projected fourth-quarter revenue ahead of the Wall Street consensus as the company continues to flex growth in the scientific instruments field.
The Massachusetts-based company said Monday it now expects fourth-quarter revenue of $970 million to $980 million. Analysts on Wall Street surveyed by FactSet had expected revenue of around $962.2 million. Bruker reported $854.5 million in revenue during the same period last year.
For the current year, Bruker expects revenue growth in the upper mid-single digits, excluding currency effects. The company has a goal of between 13% and 15% growth in adjusted earnings per share between 2025 and 2027.
Bruker issued the outlook ahead of a presentation at an industry conference. In a provided slide deck, it noted that China has been the major driver of growth over the last two decades, but the country's dominance moving forward is less clear.
In October, Bruker announced the launch of a new division, Bruker Spatial Biology, which aims to elevate industry technology with an array of spatial biology instruments, software and other services.
Shares were recently up 1.92% to $61.95 in Monday trading.
Write to Owen Tucker-Smith at owen.tucker-smith@wsj.com
(END) Dow Jones Newswires
January 13, 2025 12:33 ET (17:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.